DINESH

Sagility Ltd

Latest CMP 42
Today's Change ▼ -0.89%
52-Week High / Low 54 | 36
Price Date: 14-Aug-2026
Recommendation Strong Buy
Target Price 60
Expected Upside 18.7%
Forecast Horizon 2 Years
Historical CAGR Not Available
1,000 Invested
Today's Value
Investment Period < 5 Years

Stock Snapshot

Post Results Return
+5.6%
Mild Positive Re-rating
1-Year Target Price
56
2-Year Target Price
60
52-Week High / Low
54 / 36
20-Day Return
+2.6%
Market Cap (Cr.)
19,784
Current PE
21.6
P/BV Ratio
2.0
Dividend Yield
0.1%
Industry PE
18.6

Price Performance

Basis of our Recommendation

Sagility Ltd's recent management commentary highlights a robust growth trajectory, driven by strong demand from US healthcare payers for outsourcing administrative functions. Management's guidance for low double-digit revenue growth and stable EBITDA margins of 24-25% for FY27 reflects confidence despite near-term cost pressures from wage inflation. The strategic acquisition of CareSeed enhances Sagility's technical capabilities, positioning the company to deepen client relationships and leverage AI integration through its Synchrony platform. Vista's financial outlook aligns with these developments, projecting continued revenue growth and stable margins, supported by a conservatively financed balance sheet. However, potential headwinds include regulatory-driven wage inflation and the risk of margin compression if volume growth does not offset rising operational costs. The industry context remains favorable, with mid-cap IT firms benefiting from improving pricing power and a stable operational environment. Over the next 12-24 months, key opportunities lie in expanding service offerings and pursuing further acquisitions, while watchpoints include managing wage pressures and navigating potential revenue impacts from AI-driven efficiencies

👍 Why We Like This Stock

  • Strong demand from US healthcare payers for outsourcing services supports revenue growth
  • Strategic acquisition of CareSeed enhances technical capabilities and market reach
  • Management's focus on AI integration positions Sagility for operational efficiencies and improved service offerings

Things To Watch Out For

  • Regulatory-driven wage inflation poses a risk to margins
  • Potential margin compression if volume growth does not offset rising operational costs
  • Increased competition and client cost-cutting in the healthcare sector may impact revenue stability

Key Parameters

Balance Sheet Strength
Conservatively Financed
Market Share
Stable
Industry Outlook
Improving
Analyst View
Strong Buy
Dividend History
Consistent
FII Holdings
Stable

Financial Snapshot

Actuals Forecast
FY24 FY25 FY26 FY27 FY28
Revenue (Cr.) 4,754 5,570 7,193 7,710 8,986
Profit Before Tax (Cr.) 241 769 1,272 1,573 1,732
PBT Margin 5.1% 13.8% 1768.4% 20.4% 19.3%
Net Profit (Cr.) 129 503 917 1,139 1,254
Earnings Per Share 0.3 1.1 2.0 2.4 2.7

Analyst Recommendations

Broker Recommendation Target Price Date
Elara Capital ▲ Buy 58 22-Jul-2026
ICICI Securities ▲ Buy 54 22-Jul-2026
Jeffries ▲ Buy 54 22-Jul-2026
Kotak Securities ▲ Buy 54 22-Jul-2026
Motilal Oswal ▲ Buy 57 22-Jul-2026
Nomura ▲ Buy 58 13-May-2026
Consensus Recommendation ▲ Strong Buy
Consensus Target 55
Coverage 6 Analysts
Analysts' Viewpoint
Sagility's focus on deepening relationships with top US health insurers and expanding through capability-led acquisitions drives its positive growth trajectory. The integration of CareSeeds and BroadPath adds significant cross-selling potential, while AI and automation are leveraged for cost optimization. However, statutory wage increases in key Indian hubs and potential AI-led service cannibalization pose margin challenges. Future catalysts include seasonal US enrollment volumes and the integration of CareSeeds' platforms to enhance AI-enabled services.

Company Overview

Show Company Profile

Sagility Limited engages in the provision of business process management services to the healthcare and insurance industries in India, Jamaica, the Philippines, the United States, and Colombia. The company offers claims cost containment and management, member and provider engagement, enrolment, benefits plan building, payment integrity and billing, credentialing, clinical and case management, provider network operation services, analytics, front and back-office, administrative support provider, and data management services. It also provides utilization and care management, and population health management, as well as revenue cycle management functions, such as financial clearance, medical coding, billing, labs and durable medical equipment support, patient access and engagement, and accounts receivable follow-up services. In addition, it provides services to pharmacy benefit managers that manage prescription drugs for members under health insurance plans. Further, it offers various platforms, including document processing engine, genAI solutions for customer and member engagement, nurse assist, revenue cycle management, provider forward, enrolment and plan automation, and contract central. The company was formerly known as Sagility India Limited and changed its name to Sagility Limited in August 2025. The company was incorporated in 2021 and is based in Bengaluru, India. Sagility Limited operates as a subsidiary of Sagility B.V.